This video demonstrates the in vivo delivery of miRNA inhibitors as therapeutic agents against tumor growth in orthotopic mouse models. The intratumoral administration of synthetic miRNA inhibitors or antagomiRs allows them to bind and inhibit endogenous miRNAs, thereby causing mRNA upregulation and suppression of tumor growth.
Protocol
All procedures involving animal models have been reviewed by the local institutional animal care committee and the JoVE veterinary review board. 1. Flank Inoculation of Cells and Intratumoral antagomiR Treatment Cell preparation Engineer a Cal62 human thyroid cancer cell line (KRASG12R and p53A161D mutations) to overexpress a transgenic construct that constitutively expresses GFP and luciferase (CMV-Firefly Luc-IRES-eGFP). Select the transgenic cells by…
Divulgations
The authors have nothing to disclose.
Materials
Basement Membrane Matrix: Matrigel Basement Membrane Matrix High Concentration
Corning
#354248
AntagomiR: mirVana miRNA inhibitor
Thermo Fisher
4464088
In vivo ready
In vivo delivery reagent: Invivofectamine 3.0 Reagent
Thermo Fisher
IVF 3005
Negative control: mirVana miRNA Inhibitor, Negative Control #1
Thermo Fisher
4464077
In vivo ready
XenoLight D-Luciferin – K+ Salt Bioluminescent Substrate
PerkinElmer
122799
Diluted in PBS
In vivo imaging software: IVISLumina II Imaging System
Modelling Intratumoral Treatment with miRNA Inhibitors: A Method to Analyze the Effect of miRNA Inhibitors on Tumor Growth in Murine Model. J. Vis. Exp. (Pending Publication), e20479, doi: (2023).